2 false false false false false false false false false false true false false false false false false No description of principal activity 2023-10-01 Sage Accounts Production Advanced 2023 - FRS102_2023 26,909 26,909 2,392 2,392 24,517 xbrli:pure xbrli:shares iso4217:GBP 12915799 2023-10-01 2024-09-30 12915799 2024-09-30 12915799 2023-09-30 12915799 2022-10-01 2023-09-30 12915799 2023-09-30 12915799 2022-09-30 12915799 core:PlantMachinery 2023-10-01 2024-09-30 12915799 bus:Director1 2023-10-01 2024-09-30 12915799 core:PlantMachinery 2024-09-30 12915799 core:WithinOneYear 2024-09-30 12915799 core:WithinOneYear 2023-09-30 12915799 core:AfterOneYear 2024-09-30 12915799 core:ShareCapital 2024-09-30 12915799 core:ShareCapital 2023-09-30 12915799 core:RetainedEarningsAccumulatedLosses 2024-09-30 12915799 core:RetainedEarningsAccumulatedLosses 2023-09-30 12915799 bus:Director1 2023-09-30 12915799 bus:Director1 2024-09-30 12915799 bus:Director1 2022-09-30 12915799 bus:Director1 2023-09-30 12915799 bus:Director1 2022-10-01 2023-09-30 12915799 bus:SmallEntities 2023-10-01 2024-09-30 12915799 bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 12915799 bus:SmallCompaniesRegimeForAccounts 2023-10-01 2024-09-30 12915799 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 12915799 bus:FullAccounts 2023-10-01 2024-09-30
COMPANY REGISTRATION NUMBER: 12915799
Ranu Expert Forensic Medical Services Ltd
Filleted Unaudited Financial Statements
30 September 2024
Ranu Expert Forensic Medical Services Ltd
Statement of Financial Position
30 September 2024
2024
2023
Note
£
£
Fixed assets
Tangible assets
5
24,517
Current assets
Debtors
6
33,053
37,671
Cash at bank and in hand
47,682
24,214
--------
--------
80,735
61,885
Creditors: amounts falling due within one year
7
88,100
30,446
--------
--------
Net current (liabilities)/assets
( 7,365)
31,439
--------
--------
Total assets less current liabilities
17,152
31,439
Creditors: amounts falling due after more than one year
8
15,689
--------
--------
Net assets
1,463
31,439
--------
--------
Capital and reserves
Called up share capital
2
2
Profit and loss account
1,461
31,437
-------
--------
Shareholders funds
1,463
31,439
-------
--------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the income statement has not been delivered.
For the year ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
Ranu Expert Forensic Medical Services Ltd
Statement of Financial Position (continued)
30 September 2024
These financial statements were approved by the board of directors and authorised for issue on 24 June 2025 , and are signed on behalf of the board by:
Dr A Ranu
Director
Company registration number: 12915799
Ranu Expert Forensic Medical Services Ltd
Notes to the Financial Statements
Year ended 30 September 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities measured at fair value through profit or loss. The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for services rendered. Revenue from services is recognised over time by reference to the stage of completion of each service engagement at the end of the reporting period. The stage of completion is measured based on work performed to date relative to the total expected effort required to complete the service.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Plant and machinery
-
20% reducing balance
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
Financial instruments
Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2023: Nil).
5. Tangible assets
Plant and machinery
£
Cost
At 1 October 2023
Additions
26,909
--------
At 30 September 2024
26,909
--------
Depreciation
At 1 October 2023
Charge for the year
2,392
--------
At 30 September 2024
2,392
--------
Carrying amount
At 30 September 2024
24,517
--------
At 30 September 2023
--------
6. Debtors
2024
2023
£
£
Trade debtors
30,677
12,284
Other debtors
2,376
25,387
--------
--------
33,053
37,671
--------
--------
7. Creditors: amounts falling due within one year
2024
2023
£
£
Bank loans and overdrafts
3,060
Trade creditors
574
340
Corporation tax
67,369
27,606
Social security and other taxes
12,833
Other creditors
4,264
2,500
--------
--------
88,100
30,446
--------
--------
8. Creditors: amounts falling due after more than one year
2024
2023
£
£
Bank loans and overdrafts
15,689
--------
----
9. Director's advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:
2024
Balance brought forward
Advances/ (credits) to the director
Amounts repaid
Balance outstanding
£
£
£
£
Dr A Ranu
9,635
173,342
( 183,845)
( 868)
-------
---------
---------
----
2023
Balance brought forward
Advances/ (credits) to the director
Amounts repaid
Balance outstanding
£
£
£
£
Dr A Ranu
( 66)
139,861
( 130,160)
9,635
----
---------
---------
-------